WINSTON-SALEM, N.C., Oct. 14, 2024 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that the Company will present five posters, including one late-breaking clinical trial, at the upcoming American Society of Nephrology’s (ASN) Kidney Week being held […]

NORWOOD, Mass., Oct. 14, 2024 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, today announced it commenced operations in its new cultivation facility in Mt. Vernon, Illinois. The first harvest is expected in early 2025, at which time the Company will sell its award-winning Nature’s Heritage

CINCINNATI, Oct. 14, 2024 (GLOBE NEWSWIRE) — Hillman Solutions Corp. (Nasdaq: HLMN) (“Hillman”), a leading provider of hardware products and merchandising solutions, plans to host a conference call to discuss its results for the thirteen weeks ended September 28, 2024 on Tuesday, November 5, 2024 at 8:30 a.m. Eastern Time. Hillman will issue its earnings

Amherst, NY, Oct. 14, 2024 (GLOBE NEWSWIRE) — Aqua-Tots Swim School, the largest international swim school franchise, is proud to announce that its first facility in the state of New York is now open in the city of Amherst. The 7,000-square-foot facility offers lessons Monday through Saturday at a variety of times convenient for parents.

SystImmune, Inc (SystImmune), a clinical-stage biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for BL-M11D1, an antibody-drug conjugate (ADC) binding CD33, a protein on myeloid cells. The IND supports the initiation of a Phase 1 clinical trial, BLM11D1-HM-101, to evaluate the safety, tolerability, pharmacokinetics,

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Torrid Holdings Inc. ("Torrid Holdings Inc.") (NYSE:CURV) concerning possible violations of federal securities laws. On October 7, 2024, Torrid announced the termination of "Ms. Elizabeth Muñoz-Guzman, the [Company’s] Executive Vice President and Chief

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Nomura Holdings, Inc. ("Nomura Holdings, Inc.") (NYSE:NMR) concerning possible violations of federal securities laws. Media outlets reported on September 30, 2024, that Nomura was excluded as lead manager for several yen bond deals

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of federal securities laws. Humana is the subject of a Bloomberg article published on October 2, 2024, titled: "Humana Plunges as Insurer Falters on Medicare

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Travere Therapeutics, Inc. ("Travere Therapeutics, Inc.") (NASDAQ:TVTX) concerning possible violations of federal securities laws. Travere issued a press release on September 26, 2024, "announc[ing] a voluntary pause of enrollment in the Phase 3

Integration Between GoodData’s Data Application Platform and Witboost’s Platform to Automate Lifecycle Management, Deployment and Change Management SAN FRANCISCO, CA / ACCESSWIRE / October 14, 2024 / GoodData, a leading data analytics and business intelligence (BI) platform, and Witboost, a pioneering platform that streamlines data management, processes, and operations, today announced a strategic partnership to